Thu Mar 1 10:35:14 200717

Fetching...
 
Fake drugs are killing thousands
23 Feb 2007 15:19:00 GMT
Blogged by: Mark Snelling

Sooner or later, most travellers to southeast Asia will eventually buy a fake. I used to have drawers of the stuff - a reproduction gold Rolex was one unfortunate purchase and I'm sure the odd counterfeit designer handbag made it home as a gift. It's tempting to view the trade as harmless. If the accessories of the super-rich lose a little of their cachet, so be it.

The truly dark side of this business, however, is not the Hermes scarves or the Gucci wallets. It's the drugs.

Britain's Guardian newspaper is reporting an "epidemic" of counterfeit therapeutic drugs that it says is sweeping southeast Asia, effectively killing hundreds of thousands of patients who believe they are receiving vital - and life-saving - treatment.

Quoting Dr Paul Newton of the Oxford University Centre for Tropical Medicine, who is working in the Laotian capital Vientiane, the report says criminal manufacturers are particularly targeting a new malaria wonder-drug, artemisinin.

The real thing has proved especially effective against parasites that have become resistant to older remedies such as chloroquine. Its increasing popularity has obviously caught the eye of the counterfeiters, who mostly seem to be based in China.

According to Newton and his colleagues, bogus anti-malarials are now being manufactured on "an industrial scale", including highly sophisticated reproductions of anti-forgery holograms on the packaging.

The U.N. World Health Organisation (WHO) estimates that 200,000 of the one million malaria deaths every year would be prevented if all the drugs taken were genuine. Up to 50 percent of all drugs sold in Asia and Africa are fakes - not to be confused with generic drugs, which is the term for medicines that are identical in efficacy to big brand name drugs in every way, but are manufactured independently.

The debate goes on over the licensing and distribution of generic drugs. Meanwhile, counterfeits are flooding onto the market, including critically important anti-retrovirals for HIV/AIDS and medicine for bird flu. In 2003, the estimate for the developing world was only 25 percent.

As the Guardian reports, not only are thousands dying needlessly, but diseases themselves are becoming drug-resistant because fake medicines sometimes contain small "sub-therapeutic" doses of the active ingredient. Proving the maxim that every good lie contains at least a kernel of the truth, it fools patients into thinking the treatment is working because they will notice a slight change in their condition. But it also causes the parasite itself to mutate, survive and often strengthen.

But before we start viewing this as an exclusively Third World problem, Britain and the United States are also facing a growing threat. A report in Britain's The Independent newspaper last month revealed that the trade is switching its attentions from small-scale internet deals to pharmaceutical wholesalers supplying the National Health Service (NHS).

Depressingly, the growth in criminal activity has been driven by the growth in demand for lifestyle drugs for obesity and impotence - the amoral feeding off the insecure. Fake Viagra, for example, has reportedly been a runaway success for the gangs.

A special report in the Los Angeles Times in 2004 said that while officials were still unsure of the full extent of the counterfeit trade, they had seen a tripling in the number of cases in the previous few years.

It is almost impossible to underestimate the cynicism, venality and blank disregard for human life that the trade in fake drugs represents. But where there's a market, there's money, and where there's money, there's crime. So what if they kill a few hundred thousand people in the process?

Reuters AlertNet is not responsible for the content of external websites.

Delicio.us  |   Digg  |   NewsVine  |   Reddit                                                                                  Permalink

2 responses to “Fake drugs are killing thousands”

Please note that comments should not be regarded as the views of Reuters.
  1. hirut tebeje says:

    this is my everyday challenge. i was questioning those medical people every time but those people are not telling the truth of this fake drugs. thanks for sharing this basic information that helps me not to buy fake drugs produced by asian countries like india.

  2. Tan says:

    As a physician, generic drugs are not the same as name brand, not by far. The generic drug companies lobbied to get a bill passed that says that the generic drugs are equivilent to name brands.

    But this is far from the truth. It is not uncommon for a person to have to take 2, 3 and even 5 times the generic drugs to get the same blood level as a name brand. Now, if they would pass a law that said that they had to have Blood Level equivalence, and then have a number on the bottle that showed the percentage of the medicine that one took that got into the blood stream in 90 minutes, this would be fair.

    Why are generic drugs pushed? MONEY. A name brand drug may cost the druggest $50.00, for which the druggist can sell the drug for $60.00 making only a $10 dollar profit. The same drug in a generic may cost the pharmacist $2.00 for which the pharmacisit can sell the drug for $20.00, telling people how much cheaper it is than the $60.00 drug. Pharmacists always make more money off of generics than they do off of name brands and by a lot.

    The government laws for generics and name brands are to have molecular equivilents, the same amount of weight per weight of a given drug. But the weight does not matter, what matter's is how much of the drug gets into the blood stream to do the job. And it takes real skill and knowledge in understanding to get medicines to absorb into the human body. Many of these generics break down in the stomach, as they are not prepared correctly for best absorption. Thank You,

    Tan

Leave a Reply

Enter the code shown on the left

When you submit a comment to us we request your name, e-mail address and optionally a link to a website. Please note where you submit a website address, we may link to it via your name. By sending us a comment, you accept that we have the right to show the comment and your name to users. Although we require your email address, this will not be published on the site, and is only required to enable us to check facts with you, e.g. if you are making a claim we can not confirm easily. Additionally, if you would like your comment removed at anytime, you'll have to use this e-mail address when you contact us. To remove a comment at any time please e-mail us at blogs-(at)-reuters-(dot)-com (address obscured to avoid spam) specifying who you are and what you would like removed. We moderate all comments and will publish everything that advances the post directly or with relevant tangential information. We reserve the right to edit comments in order to maintain the quality of the comments, and may not include links to irrelevant material. We try not to publish comments that we think are offensive or appear to pass you off as another person, and we will be conservative if comments may be considered libelous. Reuters will use your data in accordance with Reuters privacy policy. Reuters Group is primarily responsible for managing your data. As Reuters is a global company your data will be transferred and available internationally, including in countries which do not have privacy laws but Reuters seeks to comply with its privacy policy.
Mark Snelling has been a freelance journalist based in London since 2004, specialising in humanitarian issues. Aside from writing part-time for AlertNet, he is also an Information Delegate with the British Red Cross. Prior to that, he worked for the International Committee of the Red Cross (ICRC) in Nairobi after several years as a foreign correspondent, based primarily in the Asia-Pacific region.

NewsBlogs by theme


AlertNet Blogs


GlobalVoices